MA40954A - DETERMINATION OF GLYCOSAMINOGLYCANE LEVELS BY MASS SPECTROMETRY - Google Patents

DETERMINATION OF GLYCOSAMINOGLYCANE LEVELS BY MASS SPECTROMETRY

Info

Publication number
MA40954A
MA40954A MA040954A MA40954A MA40954A MA 40954 A MA40954 A MA 40954A MA 040954 A MA040954 A MA 040954A MA 40954 A MA40954 A MA 40954A MA 40954 A MA40954 A MA 40954A
Authority
MA
Morocco
Prior art keywords
glycosaminoglycane
levels
determination
mass spectrometry
spectrometry
Prior art date
Application number
MA040954A
Other languages
French (fr)
Inventor
Ann Barbier
Patrick Anthony John Haslett
Hicham Naimy
Yongchang Qiu
Original Assignee
Shire Human Genetic Therapies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Human Genetic Therapies filed Critical Shire Human Genetic Therapies
Publication of MA40954A publication Critical patent/MA40954A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA040954A 2014-11-14 2015-11-12 DETERMINATION OF GLYCOSAMINOGLYCANE LEVELS BY MASS SPECTROMETRY MA40954A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462080154P 2014-11-14 2014-11-14

Publications (1)

Publication Number Publication Date
MA40954A true MA40954A (en) 2017-09-19

Family

ID=54754780

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040954A MA40954A (en) 2014-11-14 2015-11-12 DETERMINATION OF GLYCOSAMINOGLYCANE LEVELS BY MASS SPECTROMETRY

Country Status (10)

Country Link
US (1) US10578624B2 (en)
EP (1) EP3218722A1 (en)
JP (1) JP6693954B2 (en)
CN (1) CN107003324B (en)
AU (1) AU2015346064B2 (en)
CA (1) CA2967382A1 (en)
EA (1) EA035784B1 (en)
MA (1) MA40954A (en)
MX (1) MX2017006242A (en)
WO (1) WO2016077775A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6973714B2 (en) * 2017-06-09 2021-12-01 国立大学法人北海道大学 A method for assisting in the diagnosis of Niemann-Pick disease type C, a method for assisting in determining the therapeutic effect on Niemann-Pick disease type C, and a method for screening a drug for treating Niemann-Pick disease type C.
PE20210347A1 (en) * 2017-10-02 2021-02-25 Denali Therapeutics Inc FUSION PROTEINS INCLUDING ENZYMES FROM ENZYME REPLACEMENT THERAPY
CN109725068B (en) * 2017-10-27 2022-07-15 齐鲁制药有限公司 Medicine analysis method for efficiently determining ganglioside GM1 and impurities thereof
CN107991414A (en) * 2017-12-28 2018-05-04 山东大学 A kind of electrophoresis hydrophilic interaction combined gas chromatography mass spectrometry detection method of Sulodexide
EP3842800A4 (en) * 2018-08-21 2022-05-11 JCR Pharmaceuticals Co., Ltd. Analytical method for chondroitin sulfate
CN109541115B (en) * 2018-11-28 2021-04-20 西北大学 High-resolution sequential separation and accurate quantitative analysis method for sialylated sugar chain isomers
EP4019958A4 (en) * 2019-08-23 2023-08-02 JCR Pharmaceuticals Co., Ltd. Quantification method of hex4, lyso-gm1, fuc-glcnac-asn, and lyso-sulfataide included in cerebrospinal fluid
CN111721872B (en) * 2020-06-24 2021-06-25 山东大学 Method for identifying heparin and heparan sulfate and application
WO2022125560A1 (en) * 2020-12-07 2022-06-16 The Nemours Foundation Elevation of glycosaminoglycans in subjects without mucopolysaccharidosis
CN113092604B (en) * 2021-03-18 2022-04-12 福建省水产研究所(福建水产病害防治中心) Rapid detection method for three common anesthetics in aquatic product
CN115032377B (en) * 2022-08-11 2022-11-01 裕菁科技(上海)有限公司 Mucopolysaccharide storage disease biomarker and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3698563B2 (en) * 1998-09-22 2005-09-21 生化学工業株式会社 Method and kit for measuring glycosaminoglycan
JP2003265196A (en) * 2002-03-15 2003-09-24 Seikagaku Kogyo Co Ltd Method for screening mucopolysaccharidosis
AUPS293002A0 (en) * 2002-06-14 2002-07-04 Women's And Children's Hospital Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
US20050238536A1 (en) * 2004-04-21 2005-10-27 Striepeke Steven K Device and method for measuring glycosaminoglycans in body fluids
US20070161074A1 (en) * 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
US9029530B2 (en) * 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
NZ702808A (en) 2010-06-25 2016-08-26 Shire Human Genetic Therapies Methods and compositions for cns delivery of iduronate-2-sulfatase
US20130121984A1 (en) * 2011-11-07 2013-05-16 Shire Human Genetic Therapies, Inc. Biomarkers for sanfilippo syndrome and uses thereof
CN103713057B (en) 2013-12-12 2015-07-08 中国海洋大学 Method for degrading heparan sulfate and detecting heparan sulfate disaccharide composition

Also Published As

Publication number Publication date
JP2017535774A (en) 2017-11-30
US10578624B2 (en) 2020-03-03
CN107003324A (en) 2017-08-01
AU2015346064A1 (en) 2017-05-18
EA201790769A1 (en) 2017-11-30
JP6693954B2 (en) 2020-05-13
MX2017006242A (en) 2018-01-23
CN107003324B (en) 2019-09-24
EA035784B1 (en) 2020-08-10
AU2015346064B2 (en) 2021-09-23
CA2967382A1 (en) 2016-05-19
EP3218722A1 (en) 2017-09-20
US20170350900A1 (en) 2017-12-07
WO2016077775A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
NL301117I1 (en) trastuzumab deluxtecan
MA40954A (en) DETERMINATION OF GLYCOSAMINOGLYCANE LEVELS BY MASS SPECTROMETRY
DK3126395T3 (en) Multispecific antibodies
DE112015003177A5 (en) Dual Mass Flywheel
GB201616445D0 (en) Method of targeted mass spectrometric analysis
GB201408392D0 (en) Mass Analyser
SG11201702040WA (en) Mass spectrometer
SG11201610090RA (en) Cyclic dipeptide-containing composition
DE112015002271A5 (en) Dual Mass Flywheel
DK3277690T3 (en) SPIROCYCLIC COMPOUNDS
ZA201706282B (en) Solid forms of menaquinols
DK3385386T6 (en) BIOSYNTHETIC CARRIMYCIN GENCLUSTER
UY4467S (en) JAR
GB2541346B (en) Mass spectrometer
FR3024647B1 (en) TRANSAT OF PUERICULTURE
FR3029421B1 (en) PERFUME DIFFUSER BY AN AEGAGROPHIL OF POSIDONIA
FR3019594B1 (en) ADDITIONAL SECTION OF PUSH
DK3391403T3 (en) ACCELERATOR MASS SPECTROMETRY PROCEDURE
GB2536322B (en) Mass spectrometry analysis of protein variants
FR3039391B1 (en) ORTHESE OF CONTENTION
GB2534252B (en) Time of flight mass spectrometer
DE112016002352A5 (en) mass flywheel
DE112015003161A5 (en) Dual Mass Flywheel
FR3024135B1 (en) PIECE OF HARNACHEMENT
DOS2015000112S (en) GAS BOMBON